FIELD: medicine.
SUBSTANCE: invention relates to using levofloxacin or ofloxacin in a dose from 20 mg to 400 mg per day for treating microbial infection in the patient.
EFFECT: technical outcome: invention relates to the use of levofloxacin or ofloxacin in effective dosages for treating a microbial infection.
14 cl, 53 dwg, 37 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
AEROSOL FLUOROCHINOLONES AND THEIR APPLICATIONS | 2006 |
|
RU2428986C2 |
COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
USING LEVOFLOXACIN IN AEROSOL FORM FOR TREATING MUCOVISCIDOSIS | 2010 |
|
RU2563809C2 |
PHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL ACTIVITY | 2010 |
|
RU2435583C1 |
OPHTHALMIC OINTMENT FORMULATION AND METHOD FOR PREPARING SAME | 2012 |
|
RU2531937C2 |
METHODS OF TREATING PULMONARY BACTERIAL INFECTION WITH APPLICATION OF FLUOROQUINOLONES | 2010 |
|
RU2535056C2 |
PHARMACEUTICAL COMPOSITION CONTAINING FLUOROQUINOLONE ANTIBIOTIC DRUG | 2009 |
|
RU2494727C2 |
AZOLOAZINE SALTS OF FLUOROQUINOLONES, POSSESSING ANTIBACTERIAL AND ANTIVIRAL ACTION | 2014 |
|
RU2547835C1 |
COMPOSITIONS AND METHODS FOR PROTECTION AGAINST PATHOGENS AND IRRITANTS PRESENT IN AIR | 2017 |
|
RU2773149C2 |
PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
Authors
Dates
2016-11-27—Published
2006-05-18—Filed